ABCB1 and cancer: Conversely, the downregulation of ABCB1 in cancer cells leads to increased chemosensitivity to 5-FU, epirubicin, irinotecan and oxaliplatin [202,203,204,205,206], drugs that are still commonly used in the treatment of gastrointestinal carcinomas [207,208].